Royalty Pharma plc IPO Research Information

Royalty Pharma plc IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Royalty Pharma plc, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Royalty Pharma plc	RPRX - NASDAQ	$25.00-$28.00	$28.00	$44.00	77.7 million	6/16/2020
Underwriter(s): JP Morgan, Morgan Stanley, BofA Securities, Goldman Sachs, Citigroup, UBS, Evercore ISI, Cowen, SunTrust Robinson Humphrey
Co-Manager(s): BBVA, DNB Markets, Scotiabank, TD Securities
Industry: Health Care
Filing(s): Filed 2020-05-22

Royalty Pharma plc Quote & Chart - Click for current quote - RPRX

About Royalty Pharma plc (adapted from Royalty Pharma plc prospectus):
They are the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "RPRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.